Related Experiment Videos
Comparative study of affective disorders in three Asian countries. I. Differences in diagnostic classification
1Department of Neuropsychiatry, Nagasaki University School of Medicine, Japan.
Acta Psychiatrica Scandinavica
|December 1, 1988
Summary
This study standardized depression symptom evaluation across Asian centers. Diagnostic differences highlight challenges in international affective disorder research.
Area of Science:
- Psychiatry
- Epidemiology
- Cross-cultural research
Background:
- Affective disorders represent a significant global health burden.
- Low reported prevalence rates of depressive disorders in Asia necessitate further investigation.
- International collaborative studies are crucial for understanding global mental health trends.
Purpose of the Study:
- To standardize symptom evaluation for patients with depression as a preliminary step for a large collaborative study on affective disorders.
- To investigate factors contributing to the low reported prevalence of depressive disorders in Asia.
- To compare diagnostic practices across different cultural contexts.
Main Methods:
- Symptom evaluation standardization was conducted across three international centers: Nagasaki, Shanghai, and Seoul.
- Psychiatric symptoms were evaluated using a standardized approach.
- Diagnostic discrepancies were analyzed based on the International Classification of Diseases, 9th Revision (ICD-9).
Main Results:
- No significant differences were found in the evaluation of psychiatric symptoms among the three centers.
- However, notable differences emerged in diagnoses assigned using ICD-9 criteria.
- Nagasaki predominantly diagnosed 'affective psychosis depression,' while Shanghai favored 'neurotic disorder,' with Seoul showing no significant diagnostic tendency.
Conclusions:
- Standardized symptom evaluation is achievable across diverse cultural settings.
- Significant diagnostic variations exist even with standardized symptom assessment, impacting prevalence rates.
- These findings underscore the importance of addressing diagnostic variability in future international collaborative studies on affective disorders.